Celgene Corporation (CELG) Call Buyers Still Waiting for a Breakout

Celgene Corporation (NASDAQ:CELG) isn't moving much, despite the firm's agreement to collaborate with Juno Therapeutics Inc (NASDAQ:JUNO) on immunotherapy research

Jun 30, 2015 at 3:00 PM
    facebook twitter linkedin


    Celgene Corporation (NASDAQ:CELG) is sitting out the rally among biopharmaceutical stocks, despite the company inking a 10-year deal with Juno Therapeutics Inc (NASDAQ:JUNO) to develop immunotherapy treatments. Specifically, while JUNO has surged over 16%, CELG is up a mere 0.6% at $115.57 -- disappointing news for option bulls.

    During the last four weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), traders have bought to open 2.44 CELG calls for every put. To put that in perspective, the ratio was a more modest 1.45 at the end of May. In other words, bullish betting has picked up in recent weeks.

    The brokerage bunch is also exceedingly optimistic. Thirteen analysts currently rate CELG a "buy" or better, compared to three "holds" and not a single "sell." Plus, the stock's consensus 12-month price target of $137.15 stands in never-before-seen territory.

    On the charts, Celgene Corporation (NASDAQ:CELG) has struggled to break out of the $120-$122 neighborhood in recent months. Along similar lines, the stock has given back 10.5% since touching a record high of $129.06 in late March -- though it's currently found a foothold atop its 40-day moving average, located at $114.24.
     

    Stop leaving money on the table with the same old broken options trading approach...

    There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

     
    Best stocks for October and worst stocks for October
     


     


     
    Special Offers from Schaeffer's Trading Partners